chr12-56314861-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000273308.9(CNPY2):c.194C>T(p.Ser65Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
CNPY2
ENST00000273308.9 missense
ENST00000273308.9 missense
Scores
4
8
7
Clinical Significance
Conservation
PhyloP100: 7.71
Genes affected
CNPY2 (HGNC:13529): (canopy FGF signaling regulator 2) Predicted to be active in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNPY2 | NM_014255.7 | c.194C>T | p.Ser65Leu | missense_variant | 3/6 | ENST00000273308.9 | NP_055070.1 | |
CNPY2 | NM_001190991.3 | c.194C>T | p.Ser65Leu | missense_variant | 3/3 | NP_001177920.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNPY2 | ENST00000273308.9 | c.194C>T | p.Ser65Leu | missense_variant | 3/6 | 1 | NM_014255.7 | ENSP00000273308 | P1 | |
CNPY2-AS1 | ENST00000660360.2 | n.427G>A | non_coding_transcript_exon_variant | 2/2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2022 | The c.194C>T (p.S65L) alteration is located in exon 3 (coding exon 2) of the CNPY2 gene. This alteration results from a C to T substitution at nucleotide position 194, causing the serine (S) at amino acid position 65 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;.;M;.;.
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
N;N;D;N;D;N
REVEL
Benign
Sift
Benign
T;D;T;T;T;T
Sift4G
Benign
T;.;.;T;.;T
Polyphen
0.91
.;.;.;P;.;.
Vest4
0.50
MutPred
Gain of catalytic residue at P60 (P = 0.001);Gain of catalytic residue at P60 (P = 0.001);Gain of catalytic residue at P60 (P = 0.001);Gain of catalytic residue at P60 (P = 0.001);Gain of catalytic residue at P60 (P = 0.001);.;
MVP
MPC
0.42
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at